TGY2IT
VRTX icon

Timothy G. Youngquist 2020 Irrevocable Trust’s Vertex Pharmaceuticals VRTX Stock Holding History

Timothy G. Youngquist 2020 Irrevocable Trust’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-376
Closed -$168K – 476
2026
Q1 		$168K Buy
+376
New +$175K 0.07% 129

Other funds holding VRTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $180B AUM 37.51% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Timothy G. Youngquist 2020 Irrevocable Trust's VRTX Position: Q2 2026 in Review

Timothy G. Youngquist 2020 Irrevocable Trust sold out of Vertex Pharmaceuticals (VRTX) in Q2 2026, closing a stake of 376 shares — an estimated $168K sold.

Timothy G. Youngquist 2020 Irrevocable Trust first reported a position in VRTX in Q1 2026 and held it in 1 quarter. The position peaked at $168K in Q1 2026. 1,014 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • Timothy G. Youngquist 2020 Irrevocable Trust reported no remaining Vertex Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Timothy G. Youngquist 2020 Irrevocable Trust sold 376 Vertex Pharmaceuticals shares in Q2 2026, an estimated $168K.
  • Timothy G. Youngquist 2020 Irrevocable Trust first reported a position in Vertex Pharmaceuticals in Q1 2026 and held it in 1 quarter.
  • Timothy G. Youngquist 2020 Irrevocable Trust's Vertex Pharmaceuticals position peaked at $168K in Q1 2026.
  • 1,014 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Timothy G. Youngquist 2020 Irrevocable Trust's 13F filing for Q2 2026, filed 7 Aug 2026.